SELF-IMMOLATIVE MICELLE, METHODS AND USES THEREOF

Patent number:

EP25165757

No items found.

The present disclosure relates to the fleld of pharmaceutical carriers, particularly a self-immolative micelle as a drug delivery system for the treatment of tumours, namely solid cancer, in particular in the treatment of pancreatic ductal adenocarcinoma (PDAC) and its metastases. The present disclosure also encompasses the production of the micelle and a pharmaceutical composition, namely hydrogel composition.

Countries:

Portugal

Regions:

No items found.

Centers:

UNIVERSIDADE NOVA DE LISBOA

Other entities:

Sectors:

Health

Chemicals

New & Sustainable Materials

Subsectors:

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

SDG03: Good health and well-being

Applications

- Tumour-triggered drug release; - High local retention; - Enhanced efficacy with reduced toxicity; - Flexible modularity for other payloads; - Compatibility with accelerated regulatory paths. Primary: Platform for local chemotherapy delivery in solid tumours. Initial PoC: Pancreatic ductal adenocarcinoma (PDAC). Expandable to: Glioblastoma, peritoneal, head and neck, prostate, Lung Adenocarcinoma.

Comments

Other related patents

Health

Food & Agro

FEEDING AND FOOD PROCEDURE FOR PINK-RED SKIN FISH FROM AQUACULTURE, TO OBTAIN IN THEM A COLORING AND EXTERNAL APPEARANCE SIMILAR TO THOSE ORGANISMS WHEN THEY ARE OBTAINED DIRECTLY FROM THE SEA THROUGH EXTRACTIVE FISHING. (MACHINE-TRANSLATION BY GOOGLE TRAN

Countries

Spain

Health

RECOMBINANT NANNOCHLOROPSIS GADITANA PROTEIN

Countries

Spain

Health

COMPOUNDS FOR THE TREATMENT OF HIV INFECTION AND OTHER DISEASES CAUSED BY RNA VIRUSES

Countries

Spain

Get back to patents directory